Firefly Neuroscience (AIFF) EBIT (2016 - 2025)
Historic EBIT for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to -$2.7 million.
- Firefly Neuroscience's EBIT rose 3776.94% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.8 million, marking a year-over-year decrease of 1962.13%. This contributed to the annual value of -$10.1 million for FY2024, which is 22664.07% down from last year.
- Per Firefly Neuroscience's latest filing, its EBIT stood at -$2.7 million for Q3 2025, which was up 3776.94% from -$1.6 million recorded in Q2 2025.
- In the past 5 years, Firefly Neuroscience's EBIT registered a high of $493116.0 during Q2 2023, and its lowest value of -$4.3 million during Q3 2024.
- In the last 5 years, Firefly Neuroscience's EBIT had a median value of -$1.3 million in 2024 and averaged -$1.4 million.
- Per our database at Business Quant, Firefly Neuroscience's EBIT surged by 31070.16% in 2021 and then plummeted by 306276.33% in 2022.
- Quarter analysis of 5 years shows Firefly Neuroscience's EBIT stood at -$2.9 million in 2021, then skyrocketed by 64.67% to -$1.0 million in 2022, then tumbled by 54.76% to -$1.6 million in 2023, then tumbled by 119.27% to -$3.4 million in 2024, then increased by 22.7% to -$2.7 million in 2025.
- Its EBIT was -$2.7 million in Q3 2025, compared to -$1.6 million in Q2 2025 and -$2.1 million in Q1 2025.